Checking VRDN unusual options activity helps you spot when traders are making outsized bets on Viridian Therapeutics Inc before the broader market catches on. Viridian Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor VRDN unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching VRDN unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking VRDN unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and VRDN unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.
Catalysts rarely arrive without a footprint, and VRDN unusual options activity is often where that footprint shows up first. Our scanner tracks Viridian Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at VRDN unusual options volume on the call side or chasing put sweeps, Viridian Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
